By Holly Millner, Protiviti, Inc.
This guidance applies to companies that develop, manufacture, market, and sell pharmaceutical drugs or biological products, and is intended to assist these companies in implementing internal controls to ensure compliance with applicable laws and requirements of the federal health care program. This summary outlines the seven elements of an effective compliance program.